Since atherosclerosis is a multi-factorial disease, a new focus has been placed on developing strategies to increase the amount of high-density lipoprotein cholesterol (HDL-C) [3], giving rise to a new era of cholesteryl ester transfer protein (CEPT) inhibitors. The gene discussed is CETP; the disease is atherosclerosis.